1995
DOI: 10.1002/cbf.290130411
|View full text |Cite
|
Sign up to set email alerts
|

Increase of cyclin B by overexpression of cystatin α

Abstract: Degradation of cyclin B was effectively suppressed when cells were treated with ALLN (N-acetylleucylleucylnorleucinal) which inhibits proteasome, calpain and cysteine proteinase cathepsins. In order to examine which protease degrades cyclin B, the effect of a cathepsin inhibitor, cystatin alpha, was investigated. The cystatin alpha gene was inserted into an inducible expression vector, pMSG, and transfected into NIH3T3 mouse fibroblasts. The expression of cystatin alpha was induced effectively in the transfect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

1997
1997
2006
2006

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 16 publications
0
10
0
Order By: Relevance
“…After isolating G418-resistant clones, the expression of calpastatin in each clone was examined before and after treatment with a synthetic glucocorticoid, dexamethasone (Dex), as described. 39 Two of the transfected clones, TnMc-17 and -22, expressed high levels of calpastatin after treatment with Dex while the empty-vector-transfected control Tn-V cells showed barely detectable levels of calpastatin irrespective of Dex treatment ( Figure 5A). …”
Section: Sensitization To Pep By Calpain Inhibitor Allnmentioning
confidence: 93%
“…After isolating G418-resistant clones, the expression of calpastatin in each clone was examined before and after treatment with a synthetic glucocorticoid, dexamethasone (Dex), as described. 39 Two of the transfected clones, TnMc-17 and -22, expressed high levels of calpastatin after treatment with Dex while the empty-vector-transfected control Tn-V cells showed barely detectable levels of calpastatin irrespective of Dex treatment ( Figure 5A). …”
Section: Sensitization To Pep By Calpain Inhibitor Allnmentioning
confidence: 93%
“…70 Immunoblot analysis was carried out using ECL system (Amersham) as described previously. 71 The antibodies used were anti-Src (Oncogene Science), anti-PKCa, PKCg, PKCz, PKCl, PKCm and PKCy, anti-p53 (Transduction Laboratories), anti-Bax (Santa Cruz Biotechnology), anti-m-calpain and anti-m-calpain (Chemicon International, Temecula, CA, USA), anti-calpastatin (Takara, Kyoto, Japan) and anti-activated m-calpain antibodies. 48 …”
Section: Preparation Of Cell Extract and Immunoblot Analysismentioning
confidence: 99%
“…If the decrease in PKC is caused by calpain, the level of PKC might increase by a calpain inhibitor. FMD6, another DAN ‐transfected ras‐NIH clone, was treated with a calpain inhibitor, ZLLH [12], for 24 h and PKC was examined by immunoblot. FMD6 showed a similar decrease in PKCα without Dex treatment compared with a vector control, FVE8, probably due to a leaked expression of DAN (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Cells were lysed in 0.5% Nonidet P‐40, 20 mM Tris‐HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride and 50 μM N ‐acetyl‐leucyl‐leucyl‐norleucinal as described, incubated at 0°C for 10 min and centrifuged at 13 000× g for 10 min. The supernatant was then electrophoresed through an SDS‐polyacrylamide gel followed by immunoblot analysis using affinity‐purified anti‐rat DAN polyclonal antibody [3, 4], anti‐PKC antibody (Amersham), anti‐PKCα, ‐β, ‐γ, ‐δ, ‐ϵ, ‐ι, ‐μ, ‐θ, ‐λ and ‐ζ antibodies (Transduction Laboratories), and anti‐150‐kDa‐non‐erythroid α‐spectrin (fodrin) antibody [11], as described previously [12].…”
Section: Methodsmentioning
confidence: 99%